Cifrazol (Sterling Knight Pharmaceuticals,LLC)
Welcome to the PulseAid listing for the Cifrazol drug offered from Sterling Knight Pharmaceuticals,LLC. This Vitamin D [Chemical/Ingredient],Vitamin D [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sterling Knight Pharmaceuticals,LLC |
| NON-PROPRIETARY NAME: | Cifrazol |
| SUBSTANCE NAME: | CHOLECALCIFEROL; FOLIC ACID |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Vitamin D [Chemical/Ingredient],Vitamin D [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2017-01-10 |
| END MARKETING DATE: | 0000-00-00 |
Cifrazol HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cifrazol from Sterling Knight Pharmaceuticals,LLC |
| LABELER NAME: | Sterling Knight Pharmaceuticals,LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3775; 1([iU]/1; mg/1) |
| START MARKETING DATE: | 2017-01-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69336-310_d308b188-b0b5-4746-a607-d704eed19326 |
| PRODUCT NDC: | 69336-310 |
| APPLICATION NUMBER: | |
Other CHOLECALCIFEROL; FOLIC ACID Pharmaceutical Manufacturers / Labelers:
